Summary
Arginine-vasopressin (AVP) caused a marked shape change reaction and rise in [Ca2+]i in human blood platelets only when the extracellular buffer contained Mg2+ or Ca2+. At physiological concentrations of the cations the potency of AVP was higher in the presence of Mg2+ than of Ca2+. The amplitude of the shape change reaction was also greater with Mg2+ than with Ca2+, although the [Ca2+]i-rise was slightly more marked with extracellular Ca2+. The concentration of Mg2+ at which AVP showed half of its maximal effects was below the physiological plasma level of the cation, whereas the corresponding value for Ca2+ was higher. Addition of Ca2+ to the Mg2+ containing medium did not further enhance the action of AVP on platelet shape. In platelet-rich plasma the potency and efficacy of AVP in causing a shape change were similar in the presence and absence of EGTA, whereas with EDTA in the medium AVP had no effect. In conclusion, Mg2+ has an essential physiological role in AVP-induced platelet activation, which is brought about partly by release of intracellular calcium and partly by some other intracellular mechanism.
References
Affolter H, Erne P, Bürgisser E, Pletscher A (1984) Ca2+ as messenger of 5HT2-receptor stimulation in human blood platelets. Naunyn-Schmiedeberg's Arch Pharmacol 325:337–342
Dorsa DM, Petracca FM, Baskin DG, Cornett LE (1984) Localisation and characterization of vasopressin-binding sites in the amygdala of the rat brain. J Neurosci 4:1764–1770
Erne P, Mittelholzer E, Bürgisser E, Flückinger R, Bühler FR (1984) Measurement of receptor-induced changes in intracellular free calcium in human platelets. J Rec Res 4:587–604
Hallam TJ, Thompson NT, Scrutton MC, Rink TJ (1984) The role of cytoplasmic free calcium in the responses of quin-2-loaded human platelets to vasopressin. Biochem J 221:897–901
Haslam RJ, Rosson GM (1972) Aggregation of human blood platelets by vasopressin. Am J Physiol 223:958–967
Keppens S, de Wulf H (1979) The nature of the hepatic receptors involved in vasopressin-induced glycogenolysis. Biochim Biophys Acta 588:63–69
Laubscher A, Pletscher A (1979) Shape change and uptake of 5-hydroxytryptamine in human blood platelets: action of neuropsychotropic drugs. Life Sci 24:1833–1840
Penit J, Faure M, Jard S (1983) Vasopressin and angiotensin II receptors in rat aortic smooth muscle cells in culture. Am J Physiol 244:E72–82
Ringbom A (1963) A guide for the critical selection of analytical methods based on complexation reactions. In: Chemical analysis, vol 16. John Wiley, New York London, pp 1–395
Rink TJ, Smith SW, Tsien RY (1982) Cytoplasmic free Ca2+ in human platelets: Ca2+ tresholds and Ca-independent activation for shape change and secretion. FEBS Lett 148:21–26
Scrutton MC, Egan CM (1979) Bivalent cation requirements for aggregation of human blood platelets and the role of the anticoagulant. Thromb Res 14:713
Somlyo AP, Somlyo AV (1981) Effects and subcellular distribution of magnesium in smooth and striated muscle. Fed Proc 40:2667–2671
Thomas ME, Clare KA, Scrutton MC (1982) Further evidence for V1 vasopressin receptors on human platelets. Brit J Pharmacol 75:123P
Van Wimersma Greidanus TB, van Ree JM, de Wied D (1983) Vasopressin and memory. Pharmacol Ther 20:437–458
Walter R, Rudinger J, Schwartz IL (1967) Chemistry and structure-activity relations of the antidiuretic hormones. Am J Med 42:653
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Erne, P., Pletscher, A. Vasopressin-induced activation of human blood platelets: prominent role of Mg2+ . Naunyn-Schmiedeberg's Arch. Pharmacol. 329, 97–99 (1985). https://doi.org/10.1007/BF00695199
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00695199